Show
Sort by
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP
-
Rhinology Future Debates 2018, a EUFOREA report
-
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper (vol 10, 1, 2020)
-
- Journal Article
- A1
- open access
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper
-
The role of mobile health technologies in allergy care : an EAACI position paper
-
- Journal Article
- A1
- open access
Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA
-
- Journal Article
- A1
- open access
Treatment of allergic rhinitis during and outside the pollen season using mobile technology : a MASK study
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
-
European position paper on rhinosinusitis and nasal polyps 2020